Loading...
Loading...
Browse our services, roles, and resources at a glance.
Pharma + life sciences companies need clinical documentation, pharmacovigilance, regulatory affairs, and medical writing — all GxP-compliant.
Pharma compliance is non-negotiable. AB7's life sciences pool is GxP-ready by default.
Pharma + life sciences companies need clinical documentation, pharmacovigilance, regulatory affairs, and medical writing — all GxP-compliant.
We'll map your specific pharmaceuticals & life sciences ops gaps to the bench AB7 can deploy in 7–14 days.
Book the briefingWhat we hear from pharmaceuticals & life sciencesoperators isn't a strategy gap — it's an execution gap. The roadmap is fine. The spreadsheet is fine. What's missing is the bench required to actually run it. That's what we built AB7 for.
Below: the five fires we keep finding inside this category. Each one maps cleanly to one of AB7's six service pillars — which is the point of the rest of this brief.
“Most pharmaceuticals & life sciencesbuyers don't need more advice — they need staffed seats.”
Clinical trial documentation, eTMF management requires specialty staff.
Adverse event reporting, ICSR processing requires GxP-trained ops.
FDA, EMA, multi-country submission documentation specialty work.
Medical writers for regulatory + scientific publications rare.
GxP QMS documentation specialists.
One MSA covers all six. Add or drop pillars without re-papering the engagement.
GxP-compliant ops at scale
Clinical platform engineering
Multi-framework pharma compliance
R&D financial visibility
Pipeline + KOL relationship ops
Source PhD / scientist talent
A typical Pharmaceuticals & Life Sciences engagement opens with 2–3 seats and expands. All seats sit under a single MSA.
Indicative monthly rates. Final pricing varies by seniority, geography (India / Philippines) and shape. Add headcount any time without re-papering the MSA.
Outcomes tracked weekly inside your shared dashboard — not promised in a deck.
The first 14 days are setup and absorption. Real movement on metrics begins around Day 30. By Day 90, the bench is steady-state and you're measuring outcomes — not the engagement.
Most pharmaceuticals & life sciences operators recoup setup cost by Day 60 from a combination of savings + uplift on the metrics below.
Clinical trial documentation continuously up-to-date
Pharmacovigilance ICSR cycle SLA met
Regulatory submission timelines hit
Medical writing for publications + regulatory
60-70% cost savings vs US/EU pharma hires
No surprises at audit time. We sign your DPA, follow your stack, document everything in your dashboard.
We don't sell, resell, or distribute these platforms. Our remote staff operate on your existing accounts under your governance. All trademarks belong to their respective owners.
A composite drawn from real Pharmaceuticals & Life Sciences deployments. Names redacted, structure intact.
Mid-size biotech with 3 active clinical trials needed eTMF + pharmacovigilance ops at GxP standard.
AB7 placed 6-FTE GxP-trained pod (clinical docs + pharmacovigilance + regulatory).
All 3 trials audit-ready. Submission timelines hit. $480k/yr saved.
One MSA. Six pillars. A bench that already speaks pharmaceuticals & life sciences. Your first hire goes live in 7–14 days.